Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis

被引:91
作者
Cokol, Murat [1 ,2 ,3 ]
Kuru, Nurdan [3 ]
Bicak, Ece [4 ]
Larkins-Ford, Jonah [1 ,2 ,5 ]
Aldridge, Bree B. [1 ,2 ,6 ]
机构
[1] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA
[2] Harvard Med Sch, Lab Syst Pharmacol, Boston, MA 02115 USA
[3] Sabanci Univ, Fac Engn & Nat Sci, TR-34956 Istanbul, Turkey
[4] Brandeis Univ, Sci Program Biotechnol, Waltham, MA 02453 USA
[5] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA
[6] Tufts Univ, Sch Engn, Dept Biomed Engn, Medford, MA 02155 USA
来源
SCIENCE ADVANCES | 2017年 / 3卷 / 10期
关键词
MULTIDRUG-RESISTANT TUBERCULOSIS; MOXIFLOXACIN; COMBINATION; PHARMACOKINETICS; PYRAZINAMIDE; PREDICTION; LANDSCAPE; SYNERGY; REGIMEN; PA-824;
D O I
10.1126/sciadv.1701881
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Combinations of three or more drugs are used to treat many diseases, including tuberculosis. Thus, it is important to understand how synergistic or antagonistic drug interactions affect the efficacy of combination therapies. However, our understanding of high-order drug interactions is limited because of the lack of both efficient measurement methods and theoretical framework for analysis and interpretation. We developed an efficient experimental sampling and scoring method [diagonal measurement of n-way drug interactions (DiaMOND)] to measure drug interactions for combinations of any number of drugs. DiaMOND provides an efficient alternative to checkerboard assays, which are commonly used to measure drug interactions. We established a geometric framework to factorize high-order drug interactions into lower-order components, thereby establishing a road map of how to use lower-order measurements to predict high-order interactions. Our framework is a generalized Loewe additivity model for high-order drug interactions. Using DiaMOND, we identified and analyzed synergistic and antagonistic antibiotic combinations against Mycobacterium tuberculosis. Efficient measurement and factorization of high-order drug interactions by DiaMOND are broadly applicable to other cell types and disease models.
引用
收藏
页数:11
相关论文
共 34 条
  • [1] Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis
    Almeida, Deepak
    Nuermberger, Eric
    Tasneen, Rokeya
    Rosenthal, Ian
    Tyagi, Sandeep
    Williams, Kathy
    Peloquin, Charles
    Grosset, Jacques
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (10) : 4178 - 4184
  • [2] Multidrug evolutionary strategies to reverse antibiotic resistance
    Baym, Michael
    Stone, Laura K.
    Kishony, Roy
    [J]. SCIENCE, 2016, 351 (6268)
  • [3] Beppler Casey., 2016, Journal of The Royal Society Interface, V13, P20160800, DOI DOI 10.1098/RSIF.2016.0800
  • [4] BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
  • [5] METHOD FOR TESTING FOR SYNERGY WITH ANY NUMBER OF AGENTS
    BERENBAUM, MC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (02) : 122 - 130
  • [6] Chemogenomics and orthology-based design of antibiotic combination therapies
    Chandrasekaran, Sriram
    Cokol-Cakmak, Melike
    Sahin, Nil
    Yilancioglu, Kaan
    Kazan, Hilal
    Collins, James J.
    Cokol, Murat
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2016, 12 (05)
  • [7] Impact of Nonlinear Interactions of Pharmacokinetics and MICs on Sputum Bacillary Kill Rates as a Marker of Sterilizing Effect in Tuberculosis
    Chigutsa, Emmanuel
    Pasipanodya, Jotam G.
    Visser, Marianne E.
    Van Helden, Paul D.
    Smith, Peter J.
    Sirgel, Frederick A.
    Gumbo, Tawanda
    McIlleron, Helen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (01) : 38 - 45
  • [8] Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies
    Chou, Ting-Chao
    [J]. PHARMACOLOGICAL REVIEWS, 2006, 58 (03) : 621 - 681
  • [9] Cokol Murat, 2013, Curr Drug Discov Technol, V10, P106
  • [10] Systematic exploration of synergistic drug pairs
    Cokol, Murat
    Chua, Hon Nian
    Tasan, Murat
    Mutlu, Beste
    Weinstein, Zohar B.
    Suzuki, Yo
    Nergiz, Mehmet E.
    Costanzo, Michael
    Baryshnikova, Anastasia
    Giaever, Guri
    Nislow, Corey
    Myers, Chad L.
    Andrews, Brenda J.
    Boone, Charles
    Roth, Frederick P.
    [J]. MOLECULAR SYSTEMS BIOLOGY, 2011, 7